Social app to improve warfarin therapy in post-mhvr chinese patients: a randomized controlled trial

HIGHLIGHTS

• who: Litao Zhang and collaborators from the Clinical Laboratory, General Hospital Affiliated to University of Science and Technology, China have published the paper: Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial, in the Journal: Cardiovascular ue020erapeutics of 14/01/2023
• what: The study was a prospective, open label, and randomized controlled trial conducted in Cardiovascular Therapeutics Wuhan Asia Heart Hospital in China. The authors found that this model had many disadvantages; for example, the group chat usually worked on one-to bases; thus, everyone in the group could . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.